Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Careplus Group BhdXKLS:0163 Debt-to-Equity is 0.17 as of Mar. 2026, which is 11% below its 10-year median of 0.19. The stock has 5 warning signs investors should review. Among 702 Medical Devices & Instruments companies, Careplus Group Bhd ranks better than 56.98% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Careplus Group Bhd's Debt-to-Equity or its related term are showing as below:
XKLS:0163'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.19 Max: 1.41
Current: 0.17
During the past 13 years, the highest Debt-to-Equity Ratio of Careplus Group Bhd was 1.41. The lowest was 0.03. And the median was 0.19.
XKLS:0163's Debt-to-Equity is ranked better than 56.98% of 702
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs XKLS:0163: 0.17
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Careplus Group Bhd Debt-to-Equity Related Terms
Careplus Group Bhd Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Careplus Group Bhd's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0163 vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Careplus Group Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careplus Group Bhd Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Careplus Group Bhd's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Careplus Group Bhd's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careplus Group Bhd (XKLS:0163) has a Debt-to-Equity of 0.17 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Careplus Group Bhd and its competitors. This is 11% below median its historical median of 0.19. Over the past decade, Careplus Group Bhd's Debt-to-Equity has ranged from 0.03 to 1.41. According to the industry distribution chart, Careplus Group Bhd ranks #302 out of 702 companies in the Medical Devices & Instruments industry, placing it in the top 43%.
Is Careplus Group Bhd's Debt-to-Equity too high?
Careplus Group Bhd's current Debt-to-Equity of 0.17 is 11% below median its 10-year median of 0.19. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 1.41. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Careplus Group Bhd's value of 0.17 is 26.1% below this industry median. Based on the distribution chart, Careplus Group Bhd ranks #302 out of 702 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Careplus Group Bhd's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Careplus Group Bhd ranks #302 out of 702 companies for Debt-to-Equity. This puts Careplus Group Bhd in the upper half of its industry. The industry median Debt-to-Equity is 0.23. Careplus Group Bhd's value of 0.17 is 26.1% below this benchmark. Historically, Careplus Group Bhd's own Debt-to-Equity has ranged from 0.03 to 1.41 over the past decade. While the company's 10-year median is 0.19 vs. the industry median of 0.23, Careplus Group Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Careplus Group Bhd's current Debt-to-Equity of 0.17 is 26.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Careplus Group Bhd and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careplus Group Bhd's current Debt-to-Equity is 0.17, which is 11% below median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careplus Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, Careplus Group Bhd (XKLS:0163) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.09, compared to a current price of RM0.07 — trading 22.2% below its estimated fair value. The current Debt-to-Equity is 0.17, which is 11% below median its 10-year median of 0.19 and 26.1% below the Medical Devices & Instruments industry median of 0.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Careplus Group Bhd (XKLS:0163), the current Debt-to-Equity is 0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0163 has been successfully added to your 
